Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Isospaglumic Acid
2. N-(n-acetyl-l-alpha-aspartyl)-l-glutamic Acid
3. N-acetyl-1-asp-glu
4. N-acetyl-1-aspartylglutamic Acid
5. N-acetyl-1-aspartylglutamic Acid, (l)-isomer Ion
6. N-acetyl-1-aspartylglutamic Acid, Magnesium Salt
7. N-acetyl-aspartyl-glutamate
8. N-acetyl-aspartyl-glutamic Acid
9. N-acetyl-l-alpha-aspartylglutamic Acid
10. N-acetyl-l-aspartyl-l-glutamate
11. N-acetylaspartylglutamate
12. Naaga
13. Naaga Magnesium Salt
14. Naaga Sodium Salt
15. Naaxia
16. Zy 15106
17. Zy 15109
18. Zy-15106
19. Zy-15109
20. Zy15106
21. Zy15109
1. N-acetyl-1-aspartylglutamic Acid
2. N-acetyl-asp-glu-oh
3. Alpha-naag
4. Spectrum2_001481
5. Spectrum3_001845
6. 2-[(2-acetamido-3-carboxy-1-oxopropyl)amino]pentanedioic Acid
7. Chembl64966
8. Schembl288515
9. Spbio_001461
10. Schembl21403461
11. Chebi:95120
12. Kbio3_002730
13. Dtxsid10863103
14. Hms3266k17
15. Ccg-39200
16. Pdsp1_000259
17. Pdsp2_000258
18. Ncgc00095908-01
19. Ncgc00095908-02
20. Db-047960
21. Ft-0774474
22. N-acetyl-asp-glu, >=97% (tlc), Powder
23. L000426
24. Q27166900
| Molecular Weight | 304.25 g/mol |
|---|---|
| Molecular Formula | C11H16N2O8 |
| XLogP3 | -2.1 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 9 |
| Exact Mass | 304.09066547 g/mol |
| Monoisotopic Mass | 304.09066547 g/mol |
| Topological Polar Surface Area | 170 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 448 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Neurotoxins
Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. (See all compounds classified as Neurotoxins.)
Global Sales Information
Market Place
ABOUT THIS PAGE
A Spaglumic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Spaglumic Acid, including repackagers and relabelers. The FDA regulates Spaglumic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Spaglumic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Spaglumic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Spaglumic Acid supplier is an individual or a company that provides Spaglumic Acid active pharmaceutical ingredient (API) or Spaglumic Acid finished formulations upon request. The Spaglumic Acid suppliers may include Spaglumic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Spaglumic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Spaglumic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Spaglumic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Spaglumic Acid GMP manufacturer or Spaglumic Acid GMP API supplier for your needs.
A Spaglumic Acid CoA (Certificate of Analysis) is a formal document that attests to Spaglumic Acid's compliance with Spaglumic Acid specifications and serves as a tool for batch-level quality control.
Spaglumic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Spaglumic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Spaglumic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Spaglumic Acid EP), Spaglumic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Spaglumic Acid USP).
LOOKING FOR A SUPPLIER?
